Velcade injection 3mg (Bortezomib) from Janssen Pharmaceutical (YJ_code: 4291412D1024, 3mg 1 bottle) is a proteasome inhibitor indicated for the treatment of multiple myeloma and mantle cell lymphoma. It can be administered intravenously or subcutaneously, often in combination with other therapies.
Velcade injection 3mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).